- Joined
- May 3, 2021
- Messages
- 89
- Reaction score
- 93
So, I know there is a consensus among psychiatrists that antidepressants, and especially SSRIs are not addictive, contrary to - say - benzodiazepinic drugs or psychostimulants.
The thing is, I've seen some studies that DO mention that most patients being tapered off antidepressants have withdrawal symptoms (commonly named 'discontinuation symptoms' - I even heard that it was a term coined by the pharmaceutical industry to disassociate it with withdrawal, since it implies a dependency), and in my practice I've seen a lot of patients with severe discontinuation symptoms, and some of these patients maintain these for quite some time, with a few studies relating that patients stay with sexual dysfunction or emotional blunting even YEARS after discontinuation.
One systematic review mentions: "Clinicians need to add SSRI to the list of drugs potentially inducing withdrawal symptoms upon discontinuation, together with benzodiazepines, barbiturates, and other psychotropic drugs. The term 'discontinuation syndrome' that is currently used minimizes the potential vulnerabilities induced by SSRI and should be replaced by 'withdrawal syndrome'" ¹
Some studies, even go as far as saying that benzos are safer for anxiety disorders and much less dependency-prone in these conditions than once thought, and most patients will not require larger doses of, say, alprazolam or clonazepam for their panic disorder. Here is a direct quote from one meta-analysis:² "According to the systematic review, no consistent evidence emerged supporting the advantage of using TCA over BDZ in treating generalized anxiety disorder (GAD), complex phobias and mixed anxiety-depressive disorders. Indeed, BDZ showed fewer treatment withdrawals and adverse events than AD."
There are even some claims about tolerance in the oppositional model, and patients requiring higher doses as time goes on, something I've seen in some patients in my practice.³
Now, I know these studies are quite controversial, and I'll put the citations in the end here, but I was wondering from other practitioners what have you observed in terms of SSRI safety, withdrawal, and 'addictive' potential, as well as it's BDZ counterpart on anxiety disorders.
¹ Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychother Psychosom. 2015;84(2):72-81. doi: 10.1159/000370338. Epub 2015 Feb 21. PMID: 25721705.
² Offidani E, Guidi J, Tomba E, Fava GA. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom. 2013;82(6):355-62. doi: 10.1159/000353198. Epub 2013 Sep 20. PMID: 24061211.
³ Fava GA, Cosci F. Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs. J Clin Psychiatry. 2019 Nov 26;80(6):19com12794. doi: 10.4088/JCP.19com12794. PMID: 31774947.
The thing is, I've seen some studies that DO mention that most patients being tapered off antidepressants have withdrawal symptoms (commonly named 'discontinuation symptoms' - I even heard that it was a term coined by the pharmaceutical industry to disassociate it with withdrawal, since it implies a dependency), and in my practice I've seen a lot of patients with severe discontinuation symptoms, and some of these patients maintain these for quite some time, with a few studies relating that patients stay with sexual dysfunction or emotional blunting even YEARS after discontinuation.
One systematic review mentions: "Clinicians need to add SSRI to the list of drugs potentially inducing withdrawal symptoms upon discontinuation, together with benzodiazepines, barbiturates, and other psychotropic drugs. The term 'discontinuation syndrome' that is currently used minimizes the potential vulnerabilities induced by SSRI and should be replaced by 'withdrawal syndrome'" ¹
Some studies, even go as far as saying that benzos are safer for anxiety disorders and much less dependency-prone in these conditions than once thought, and most patients will not require larger doses of, say, alprazolam or clonazepam for their panic disorder. Here is a direct quote from one meta-analysis:² "According to the systematic review, no consistent evidence emerged supporting the advantage of using TCA over BDZ in treating generalized anxiety disorder (GAD), complex phobias and mixed anxiety-depressive disorders. Indeed, BDZ showed fewer treatment withdrawals and adverse events than AD."
There are even some claims about tolerance in the oppositional model, and patients requiring higher doses as time goes on, something I've seen in some patients in my practice.³
Now, I know these studies are quite controversial, and I'll put the citations in the end here, but I was wondering from other practitioners what have you observed in terms of SSRI safety, withdrawal, and 'addictive' potential, as well as it's BDZ counterpart on anxiety disorders.
¹ Fava GA, Gatti A, Belaise C, Guidi J, Offidani E. Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review. Psychother Psychosom. 2015;84(2):72-81. doi: 10.1159/000370338. Epub 2015 Feb 21. PMID: 25721705.
² Offidani E, Guidi J, Tomba E, Fava GA. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis. Psychother Psychosom. 2013;82(6):355-62. doi: 10.1159/000353198. Epub 2013 Sep 20. PMID: 24061211.
³ Fava GA, Cosci F. Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs. J Clin Psychiatry. 2019 Nov 26;80(6):19com12794. doi: 10.4088/JCP.19com12794. PMID: 31774947.